Somatostatin Receptor Expression in GH-Secreting Pituitary Adenomas Treated with Long-Acting Somatostatin Analogues in Combination with Pegvisomant

BACKGROUND: Growth hormone-secreting pituitary adenomas (somatotroph adenoma) predominantly express somatostatin receptors (SSTRs) subtypes 2 and 5. Higher SSTR2 expression on somatotroph adenomas results in a better response to somatostatin analogues (SSAs), which preferentially bind, but also down...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Neuroendocrinology
Auteurs principaux: Franck, Sanne E., Gatto, Federico, van der Lely, Aart Jan, Janssen, Joseph A.M.J.L., Dallenga, Alof H.G., Nagtegaal, A. Paul, Hofland, Leo J., Neggers, Sebastian J.C.M.M.
Format: Artigo
Langue:Inglês
Publié: S. Karger AG 2017
Sujets:
Original Paper
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5475231/
https://ncbi.nlm.nih.gov/pubmed/27455094
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000448429
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires